Imbalance in endothelial vasoactive factors as a possible cause of cyclosporin toxicity: A role for endothelin-converting enzyme

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 5, 2000, Pages 395-401

  Gonzalez Santiago L ^a,b,c,d,e,f   Lopez Ongil S ^a,b,c,d,e,f   Lamas, S ^a,b,c,d,e,f   Quereda, C ^a,b,c,d,e,f   Rodriguez Puyol M ^a,b,c,d,e,f   Rodriguez Puyol D ^a,b,c,d,e,f  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b CIB ^*

^c CSIC   (Spain)

^d Instituto Reina Sofia de Investigacion Nefrologica   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

^f HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033747984     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.110370     Document Type: Article

References (48)

1. Cyclosporine
2. Acute and chronic nephrotoxicity associated with immunosuppressive drugs
3. Effect of cyclosporine A treatment on vascular reactivity of the rat thoracic aorta
4. Cyclosporin-induced endothelial cell injury
5. De-novo hypertension after liver transplantation
6. Cyclosporine-induced hypertension precedes renal dysfunction and sodium retention in man
7. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells
8. Role of endothelin in cyclosporine-induced glomerular dysfunction
9. Stimulation of endothelin mRNA and secretion in human endothelial cells by FK-506
10. Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat
11. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: Effect of L-arginine
12. Vascular mechamisms of cyclosporin-induced hypertension in the rat
13. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension
14. Effects of cyclosporine or FK 506 in chronic colitis
15. Nitric oxide in cyclosporine A-induced hypertension: Role of protein kinase C
16. Role of nitric oxide in cyclosporine A-induced hypertension
17. Role of NO in cyclosporin nephrotoxicity: Effects of chronic NO inhibition and NO synthase gene expression
18. Role of reactive oxygen species in the signaling cascade of cyclosporine A-mediated up-regulation of NOS3 in vascular endothelial cells
19. A novel potent vasoconstrictor peptide produced-by vascular endothelial cells
20. Endothelin-converting enzymes
21. Mammalian membrane metallopeptidase: NEP, ECE, Kell and PEX
22. Molecular pharmacology of endothelin converting enzyme
23. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells
24. ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1
25. Single-dose captopril administration in DOCA/salts rats: Reduction of hypotensive effect by indomethacin
26. Intranephron distribution and regulation of endothelin-converting enzyme-1 in cyclosporin A-induced acute renal failure in rats
27. Effects of ciclosporine A on the synthesis, excretion, and metabolism of endothelin in the rat
28. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction
29. Localization of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells
30. Identification and characterization of endothelin converting activity in cultured bovine endothelial cells
31. Sandwich-type enzyme immunoassay for big endothelin-I in plasma: Concentrations in healthy human subjects unaffected by sex or posture
32. Endothelin antagonists for hypertension and renal disease
33. Nitric oxide/endothelin balance after nephron reduction
34. Endothelial dysfunction in hypertension: Fact or fancy?
35. Cyclosporin A induces endothelin-1 release from cultured rat vascular smooth muscle cells
36. Increased concentration of endothelin messenger RNA in the mesenteric arteries of cyclosporine-induced hypertensive rats
37. Cyclosporine nephrotoxicity
38. Cyclosporine nephrotoxicity: Studies in laboratory animals
39. Experimental cyclosporine A nephrotoxicity
40. A toxicological study in rats receiving immunotherapeutic doses of cyclosporine A
41. Cyclosporine A increases nitric oxide activity in vivo
42. Regulation of endothelial nitric oxide synthase expression by cyclosporin A in bovine aortic endothelial cells
43. Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1
44. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity
45. Cyclosporin A increases nitric oxide activity in vivo
46. 2+
47. Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation
48. Endothelin converting enzyme-1 gene expression in the kidney of spontaneously hypertensive rats